Clinical Trials Directory

Trials / Completed

CompletedNCT05550844

Emphysema and FLNA Mutation (E-FLNA)

Frequency and Characteristics of Emphysema in Patients With a FLNA Gene Mutation

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Some sparse scientific data support the hypothesis that otherwise unexplained emphysema may be associated with FLNA mutation. This prospective, monocentric, cross-sectional study aimed to describe the frequency of emphysema in patients carrying an FLNA mutation. Patients with FLNA mutations who accept the study will benefit from a chest physician's clinical examination, respiratory function tests and a chest scan. The primary endpoint is to describe emphysema's frequency in patients carrying FLNA mutation. The other objectives are to describe emphysema's features in these patients and to describe their lung function abnormalities. The final goal is to confirm the association between unexplained emphysema and FLNA mutation.

Conditions

Interventions

TypeNameDescription
RADIATIONChest HRCTA chest HRCT to identify emphysema
GENETICblood analysisIf emphysema is identified, a blood analysis will be performed to exclude known causes of emphysema (Alpha-1 antitrypsin deficiency, PTPN6 mutation)
OTHERLung function testsLung function tests will be performed in accordance with ATS/ERS technical standard

Timeline

Start date
2023-02-01
Primary completion
2023-10-23
Completion
2023-10-23
First posted
2022-09-22
Last updated
2026-02-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05550844. Inclusion in this directory is not an endorsement.